Skip to main content

Advertisement

Log in

Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The natural form of the human immunodeficiency virus type one reverse transcriptase (HIV‐1 RT) found in virion particles is a heterodimer composed of the p66 and p51 subunits. The catalytic activity resides in the larger subunit in the heterodimeric (p66/p51) enzyme while in the monomeric form it is inactive. In contrast, Murine leukemia virus RT (MuLV RT) is functionally active in the monomeric form. In the primary amino acid sequence alignment of MuLV RT and HIV‐1 RT, we have identified three specific regions in MuLV RT, that were missing in HIV‐1 RT. In a separate study, we have shown that a chimeric RT construct comprising of the polymerase domain of HIV‐1 RT and RNase-H domain of MuLV RT is functionally active as monomer [20]. In this communication, we demonstrate that insertion of a peptide (corresponding to amino acid residues 480–506) from the connection subdomain of MuLV RT into the connection subdomain of HIV‐1 RT (between residues 429 and 430) results in a functionally active monomeric chimeric RT. Furthermore, this chimeric enzyme does not dimerize with exogenously added p51 subunit of HIV‐1 RT. Functional analysis of the chimeric RT revealed template specific variations in its catalytic activity. The chimeric enzyme catalyzes DNA synthesis on both heteropolymeric DNA and homopolymeric RNA (poly rA) template but curiously lacks reverse transcriptase ability on heteropolymeric RNA template. Similar to MuLV RT, the polymerase activity of the chimeric enzyme is not affected by acetonitrile, a reagent which dissociates dimeric HIV‐1 RT into inactive monomers. These results together with a proposed 3‐D molecular model of the chimeric enzyme suggests that the insertion of the missing region may induce a change in the spatial position of RNase H domain such that it is functionally active in monomeric conformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gilboa E, Mitra SW, Goff S, Baltimore DA: Detailed model of reverse transcription and tests of crucial aspects. Cell 18: 93–100, 1979

    Google Scholar 

  2. Levine JG, Hatfield D, Oroszlan S, Rein A: In: A.M. Skalka, S.P. Goff (eds). Reverse Transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993

    Google Scholar 

  3. Molling K, Bolognesi DP, Bauer H, Busen W, Plassmann HW, Hausen P: Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nature - New Biol 234: 240–243, 1971

    Google Scholar 

  4. Varmus H, Swanstrom R: In: R. Weiss, N. Teich, H. Varmus, J. Coffin (eds). RNA Tumor Virus. Cold Spring harbor Laboratory Press, Cold Spring Harbor, NY, 1985, pp 75–134

    Google Scholar 

  5. Keller W, Crouch R: Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin. Proc Natl Acad Sci USA 69: 3360–3364, 1972

    Google Scholar 

  6. Gerard GF, Grandgenett DP: Purification and characterization of the DNA polymerase and RNase-H activities in Moloney murine sarcomaleukemia virus. J Virol 15: 785–797, 1975

    Google Scholar 

  7. diMarzo-Veronese F, Copeland TD, DeVico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG: Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231: 1289–1291, 1986

    Google Scholar 

  8. Davies JF, Hostomska Z, Hostomsky Z, Jordan SR, Matthews DA: Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 252: 88–95, 1991

    Google Scholar 

  9. North TW, Cronn RC, Remington KM, Tandberg RT, Judd RC: Characterization of reverse transcriptase from feline immunodeficiency Virus. J Biol Chem 265: 5121–5128, 1990

    Google Scholar 

  10. Le Grice SFJ, Ette R, Mills J, Mous J: Comparison of the human immunodeficiency virus type 1 and 2 proteases by hybrid gene construction and trans-complementation. J Biol Chem 264: 14902–14908, 1989

    Google Scholar 

  11. Mous J, Heimer EP, Le Grice SFJ: Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli. J Virol 62: 1433–1436, 1988

    Google Scholar 

  12. Varmus H, Swantrom R: In: R. Weiss, N. Teich, H. Varmus, J. Coffin (eds). RNA Tumor Virus. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1984, pp 369–512

    Google Scholar 

  13. Wondrak EM, Lower J, Kurth R: Functional purification and enzymatic characterization of the RNA-dependent DNA polymerase of the human immunodeficiency virus. J Gen Virol 67: 2791–2797, 1986

    Google Scholar 

  14. Lightfoote M, Coligan JE, Folks TM, Fauci AS, Martin M A, Venkatesan S: Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus. J Virol 60: 771–775, 1986

    Google Scholar 

  15. Hostomsky Z, Hostomska Z, Fu TB, Taylor J: Reverse transcriptase of human immunodeficiency virus type 1: Functionality of subunits of the heterodimer in DNA synthesis. J Virol 66: 3179–3182, 1992

    Google Scholar 

  16. LeGrice SFJ, Naas T, Wohlgensinger B, Schatz O: Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J 10: 3905–3911, 1991

    Google Scholar 

  17. Harris D, Lee R, Misra HS, Pandey PK, Pandey VN: The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer. Biochemist y 37: 5903–5908, 1998

    Google Scholar 

  18. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA: Crystal structural at 3.5A resolution of HIV-1 RT complexed with an inhibitor. Science 256: 1783–1790, 1992

    Google Scholar 

  19. Wang J, Smerdon SJ, Jager J, Kohlstaedt LA, Rice PA, Friedman JM, Steitz TA: Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc Natl Acad Sci USA 91: 7242–7246, 1994

    Google Scholar 

  20. Misra HS, Pandey PK, Pandey VN: An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer. J Biol Chem 273: 9785–9789, 1998

    Google Scholar 

  21. Maxam A, Gilbert W: Sequencing end-labeled DNA with base-specific chemical cleavages. Meth Enzymol 65: 499–560, 1980

    Google Scholar 

  22. Arts EJ, Li X, Gu Z, Kleiman L, Parniak M, Wainberg MA: Comparison of deoxyoligonucleotide and t-RNAlys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. Biol Chem 269: 14672–14680, 1994

    Google Scholar 

  23. Pandey VN, Kaushik N, Rege N, Sarafianos SG, Yadav PNS, Modak MJ: Role of methionine 184 of human immunodeficiency virus typereverse transcriptase in the polymerase function and fidelity of DNA synthesis. Biochemistry 35: 2168–2179, 1996

    Google Scholar 

  24. Kaushik N, Harris D, Rege N, Modak MJ, Yadav PNS, Pandey VN: Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis. Biochemistry 36: 14430–14438, 1997

    Google Scholar 

  25. Chowdhury K, Kaushik N, Pandey VN, Modak MJ: Elucidation of the role of arg 110 of murine leukemia virus reverse transcriptase in the catalytic mechanism: Biochemical characterization of mutant enzymes. Biochemistry 35: 16610–16620, 1996

    Google Scholar 

  26. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350–1354, 1985

    Google Scholar 

  27. Roth M, Tanese N, Goff S P: Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J Biol Chem 260: 9326–9335, 1985

    Google Scholar 

  28. Lee R, Kaushik N, Modak MJ, Vinayak R, Pandey VN: Polyamide nucleic acid targeted to the primer binding site of the HIV-1 RNA genome blocks in vitro HIV-1 reverse transcription. Biochemistry 37: 900–910, 1998

    Google Scholar 

  29. Hsieh JC, Zinnen S, Modrich P: Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus-1 reverse transcriptase. J Biol Chem 268: 24607–24613, 1993

    Google Scholar 

  30. Kaushik N, Rege N, Sarafianos SG, Yadav PNS, Modak MJ, Pandey VN: Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. Biochemistry 35: 11536–11546, 1996

    Google Scholar 

  31. Modak MJ, Marcus SL: Purification and properties of Rauscher leukemia virus DNA polymerase and selective inhibition of mammalian viral reverse transcriptase by inorganic phosphate. J Biol Chem 252: 11–19, 1977

    Google Scholar 

  32. Telesnitsky A, Goff SP: RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template. Proc Natl Acad Sci USA 90: 1276–1280, 1993

    Google Scholar 

  33. Harris D, Kaushik N, Pandey PK, Yadav PNS, Pandey VN: Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase. J Biol Chem 273: 33624–33634, 1998

    Google Scholar 

  34. Divita G, Restle T, Goody RS: Characterization of the dimerization process of HIV-1 reverse transcriptase heterodimer using intrinsic protein fluorescence. FEBS Lett 324: 153–158, 1993

    Google Scholar 

  35. Jonckheere H, Taymans JM, Balzarini J, Velazquez S, Camarasa MJ, Desmyter J, De Clercq E, Anne J: Resistance of HIV-1 reverse transcriptase against [2', 5'-bis-O-(tert-butyldimethylsilyl)-3'spiro-5"-(4"-amino-1"-oxathiole-2",2"-dioxide)] (TSAO) derivatives is determined by the mutation Glu 138 → Lys on the p51 subunit. J Biol Chem 269: 25255–25258, 1994

    Google Scholar 

  36. Sharma SK, Basu A, Fan N, Evans DB: Engineering of the humanimmunodeficiency-virus-type-1 (HIV-1) reverse transcriptase gene to prevent dimerization of the expressed chimeric protein: purification and characterization of a monomeric HIV-1 reverse transcriptase. Biotech Appl Biochem 19: 155–167, 1994

    Google Scholar 

  37. Huang H, Chopra R, Verdine GL, Harrison S: Structure of a covalently trapped catalytic complex of HIV-1RT: Implication for drug resistance. Science 282: 1669–1675, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandey, P.K., Kaushik, N., Talele, T.T. et al. Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation. Mol Cell Biochem 225, 135–144 (2001). https://doi.org/10.1023/A:1012278308154

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012278308154

Navigation